1. Dougherty TJ. Wavelength and light dose dependence in tumour phototherapy with hematoporphyrin derivative.Br J Cancer 1986,52:43–9
2. Reddi E, Zhou C, Biolo R et al. Liposome or LDL-administered Zn(II)-phthalocyanme as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency.Br J Cancer 1990,61:407–11
3. Shopova M, Mantareva V, Krastev K et al. Comparative pharmacokinetic and photodynamic studies with Zn(II)-phthalocyanine in hamster bearing an induced or transplanted rhabdomyosarcoma.J Photochem Photobiol [B] 1992,16:83–9
4. Shopova M, Graschev G, Urumov I, Idakieva K. Comparative investigations of porphyrins as photosensitizers on experimental colon carcinoma. In: Jori G, Perria C (eds)Photodynamic Therapy of Tumours and Other Diseases. Padova: Edizioni Libreria Progetto, 1985:231–4
5. Wohrle D, Shopova M, Muller S et al. Experimental photodynamic therapy with Zn(II)-naphthalocyanine compounds. In: Spinelli P, Dal Fante M, Marchesini R (eds)Photodynamic Therapy and Biomedical Lasers. Amsterdam: Excerpta Medica, 1992:545–8